什么决定猴痘疫苗接种?评估男男性行为者接种意愿与其他因素对接种的影响
在荷兰阿姆斯特丹队列研究的492名男男性行为者中,2022年7月猴痘疫苗接种活动前开展在线调查,2022年8月后自报接种情况。380人(77%)有高接种意愿,238人(48%)至少接种一剂;高意愿与接种显著相关(β=1.1,95%CI=0.6-1.5),但175/380(46%)高意愿者未接种。在允许意愿决定因素直接作用于接种的模型中,意愿效应不显著,仅感知感染风险较高显著增加接种(β=0.42,95%CI=0.26-0.59),有稳定伴侣降低接种概率(β=-0.59,95%CI=-1.0- -0.18)。
要点
- 492名男男性行为者中77%有高接种意愿,但仅48%至少接种一剂。
- 高接种意愿者中46%(175/380)未接种疫苗。
- 感知感染风险较高显著增加接种(β=0.42,95%CI=0.26-0.59)。
核心结论
- 男男性行为者猴痘疫苗接种意愿高,但高意愿不一定导致接种;感知风险可能在接种中起更关键作用,可能与接种资格标准及疫苗可及性演变有关。
研究设计与样本
- 阿姆斯特丹队列研究(ACS)参与者(均为男男性行为者)于2022年7月猴痘疫苗接种活动前完成在线调查,2022年8月后研究访视时自报接种情况,采用基于计划行为理论(TPB)的结构方程模型(SEM)联合评估接种意愿与接种的关联及意愿决定因素。
主要发现
- 492名男男性行为者(中位年龄46岁)纳入分析,380人(77%)有高接种意愿,238人(48%)至少接种一剂。
- 仅含意愿与接种直接关系的第一个模型中,高接种意愿与接种显著相关(β=1.1,95%CI=0.6-1.5)。
- 175/380(46%)高接种意愿者未接种。
- 第二个模型拟合优于第一个模型,意愿对接种的效应不显著,仅感知感染风险较高显著增加接种(β=0.42,95%CI=0.26-0.59)。
- 有稳定伴侣降低接种概率(β=-0.59,95%CI=-1.0- -0.18)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In response to the mpox outbreak, vaccination was offered in the Netherlands to men who have sex with men (MSM) at increased risk for mpox. Successful vaccination campaigns are leveraged by high intent-to-vaccinate, yet intent might not always lead to uptake. Therefore, we assessed the impact of intent-to-vaccinate and other factors on vaccination uptake among participants of the Amsterdam Cohort Studies (ACS). METHOD: In July 2022, prior to the mpox vaccination campaign, we distributed an online survey regarding mpox intent-to-vaccinate, as well as e.g. beliefs, attitude, subjective norms, and perception of risk among ACS participants (all MSM). Vaccination uptake was self-reported during study visits after August 2022. The association between vaccination intent and uptake, and determinants of intent, was jointly assessed using a structural equation model (SEM) based on components of the Theory of Planned Behavior (TPB). In a second SEM, determinants of intent were allowed to have a direct effect on vaccination uptake. RESULTS: 492 MSM (median age = 46 years) were included in analyses. 380 (77%) had high intent-to-vaccinate and 238 (48%) received at least one vaccine dose. In the first model with a direct relation between intent and uptake only, TBP components predicted intent as expected, and high intent-to-vaccinate was significantly associated with getting vaccinated (β = 1.1, 95%CI = 0.6-1.5). However, 175/380 (46%) participants with high intent-to-vaccinate did not get vaccinated. The second model had an improved model fit compared to the first model. The effect of intent on uptake was non-significant, and only perceiving to be at higher risk of infection significantly increased vaccination uptake later on (β = 0.42, 95%CI = 0.26-0.59). Having a steady relationship decreased the probability of vaccination (β = -0.59, 95%CI = -1.0- -0.18). CONCLUSIONS: While intent-to-vaccinate for mpox was high among MSM, high intent did not necessarily result in vaccine uptake. Mpox risk perception might have played a more pivotal role in getting vaccinated, which may be related to the evolution of vaccination eligibility criteria and accessibility to the vaccine.
引用
- Jongen VW, Groot Bruinderink ML, Boyd A, et al. What determines mpox vaccination uptake? Assessing the effect of intent-to-vaccinate versus other determinants among men who have sex with men. Vaccine. 2023. PMID: 38072753. doi:10.1016/j.vaccine.2023.12.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。